Tevogen Bio Holdings Inc. Logo

Tevogen Bio Holdings Inc.

Developing precision, off-the-shelf T cell therapies for cancer, infections, and neuro disorders.

TVGN | US

Overview

Corporate Details

ISIN(s):
US88165K1016 (+2 more)
LEI:
Country:
United States of America
Address:
15 INDEPENDENCE BOULEVARD, SUITE #210, 7059 WARREN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company developing off-the-shelf, precision T cell therapies. The company leverages its proprietary ExacTcell™ technology platform, which harnesses the power of CD8+ cytotoxic T lymphocytes (CTLs) to treat infectious diseases, cancers, and neurological disorders. Its approach focuses on targeting antigens present only on diseased cells to enhance safety and preserve healthy tissue. A core part of Tevogen's mission is to create commercially attractive, economically viable, and affordable therapies to address the unmet needs of large patient populations. The company also utilizes artificial intelligence (Tevogen.AI) to accelerate target detection and product development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Tevogen Bio Holdings Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Tevogen Bio Holdings Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Tevogen Bio Holdings Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PALISADE BIO, INC. Logo
Developing oral precision therapies for inflammatory and fibrotic intestinal diseases like colitis.
United States of America
PALI
PALVELLA THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing topical therapies for rare genetic skin diseases.
United States of America
PVLA
Pangen Biotech Inc. Logo
Develops biosimilars and provides CHO-based CDMO services for the global biopharma industry.
South Korea
222110
Pasithea Therapeutics Corp. Logo
Developing innovative therapeutics for CNS disorders (ALS, MS) and RASopathies.
United States of America
KTTA
Pelthos Therapeutics Inc. Logo
Biopharma with an approved gel for molluscum, advancing a nitric oxide-based pipeline.
United States of America
PTHS
Pentixapharm Holding AG Logo
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
Germany
PTP
PeopleBio, Inc. Logo
Develops blood tests for early diagnosis of neurodegenerative diseases like Alzheimer's.
South Korea
304840
PEPTONIC Medical AB Logo
Develops clinically proven self-care products for women's intimate health.
Sweden
PMED
Develops sustained-release peptide medicines for chronic & neurodegenerative disorders.
South Korea
087010
PERRIGO Co plc Logo
World's largest manufacturer of store-brand OTC consumer health products.
United States of America
PRGO

Talk to a Data Expert

Have a question? We'll get back to you promptly.